MyFinsight
Home
Blog
About
Contact
Download
Download image
Distributors And Strategic
Partners
$16,460,000
(11.38%↑ Y/Y)
Direct
$8,603,000
(12.96%↑ Y/Y)
Revenue From Contract
With Customer...
$11,751,000
(-9.95%↓ Y/Y)
Revenue From Contract
With Customer...
$249,000
(117.26%↑ Y/Y)
Net loss
-$8,198,000
(60.43%↑ Y/Y)
Benefit from income
taxes
-$401,000
(76.28%↑ Y/Y)
Gain (loss) on
foreign currency...
$9,321,000
(320.63%↑ Y/Y)
All Other Countries
$25,063,000
(11.92%↑ Y/Y)
DE
$11,751,000
(-9.95%↓ Y/Y)
US
$249,000
(65.33%↑ Y/Y)
Loss before benefit
from income taxes
-$8,599,000
(61.63%↑ Y/Y)
Total other income
(expense), net
$6,150,000
(209.36%↑ Y/Y)
Revenue, net
$37,063,000
(4.13%↑ Y/Y)
Interest expense, net
-$2,612,000
(-86.69%↓ Y/Y)
Loss on abandoned
patents
$559,000
Loss from operations
-$14,749,000
(12.13%↑ Y/Y)
Gross profit
$26,491,000
(5.43%↑ Y/Y)
Cost of goods sold
$10,572,000
(0.99%↑ Y/Y)
Total operating
expenses
$41,240,000
(-1.60%↓ Y/Y)
Selling, general and
administrative
$35,645,000
(1.86%↑ Y/Y)
Research and
development, net of grant...
$5,085,000
(-26.48%↓ Y/Y)
Restructuring
$510,000
Back
Back
Income Statement
source: myfinsight.com
Cytosorbents Corp (CTSO)
Cytosorbents Corp (CTSO)